Conferees Set $1.991 Bil. NCI Budget, Ax Earmark For Breast Cancer, But Find $210 Mil. In Defense
In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award
Harkin Withdraws Amendment Allow NIH To Bypass INDS
Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited
NCI Issues 8 Awards, 12 Feasibility Grants, In New SPORE Program
Cancer Act Impact; Mortality Decline; DeVita Tells ACCC
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









